Display options
Share it on

Children (Basel). 2021 Oct 04;8(10). doi: 10.3390/children8100887.

Growth Retardation in the Course of Fanconi Syndrome Caused by the 4977-bp Mitochondrial DNA Deletion: A Case Report.

Children (Basel, Switzerland)

Ting Li, Zhihong Lu, Jingjing Wang, Junyi Chen, Haidong Fu, Jianhua Mao

Affiliations

  1. Department of Nephrology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, 3333 Binsheng Road, Hangzhou 310052, China.

PMID: 34682152 PMCID: PMC8535084 DOI: 10.3390/children8100887

Abstract

Fanconi syndrome is one of the primary renal manifestations of mitochondrial cytopathies caused by mitochondrial DNA (mtDNA) mutation. The common 4977-bp mtDNA deletion has been reported to be associated with aging and diseases involving multiple extrarenal organs. Cases of Fanconi syndrome caused by the 4977-bp deletion were rarely reported previously. Here, we report a 6-year-old girl with growth retardation in the course of Fanconi syndrome. She had mild ptosis and pigmented retinopathy. Abnormal biochemical findings included low-molecular-weight proteinuria, normoglycemic glycosuria, increased urine phosphorus excretion, metabolic acidosis, and hypophosphatemia. Growth records showed that her body weight and height were normal in the first year and failed to thrive after the age of three. Using a highly sensitive mtDNA analysis methodology, she was identified to possess the common 4977-bp mtDNA deletion. The mutation rate was 84.7% in the urine exfoliated cells, 78.67% in the oral mucosal cells, and 23.99% in the blood sample. After three months of oral coenzyme Q10 and levocarnitine treatment in combination with standard electrolyte supplement, her condition was improved. This is a report of growth retardation as the initial major clinical presentation of Fanconi syndrome caused by the deletion of the 4977-bp fragment. Renal tubular abnormality without any other extrarenal dysfunction may be an initial clinical sign of mitochondrial disorders. Moreover, considering the heterogeneity of the phenotypes associated with mtDNA mutations, the risk of developing Kearns-Sayre syndrome (KSS) with age in this patient should be noted because she had ptosis, retinal involvement, and changes in the brain and skeletal muscle.

Keywords: 4977-bp deletion; Fanconi syndrome; children; growth retardation; mitochondrial DNA

References

  1. Pediatr Nephrol. 2021 Jan;36(1):9-17 - PubMed
  2. Pediatr Clin North Am. 2019 Feb;66(1):159-167 - PubMed
  3. Am J Med Genet. 1991 Mar 15;38(4):583-7 - PubMed
  4. J Inherit Metab Dis. 1994;17(3):298-300 - PubMed
  5. Pediatr Res. 1991 Oct;30(4):327-30 - PubMed
  6. Eur J Med Genet. 2009 Jan-Feb;52(1):23-6 - PubMed
  7. Eur J Pediatr. 2013 Apr;172(4):557-61 - PubMed
  8. Medicine (Baltimore). 2019 Jul;98(27):e16302 - PubMed
  9. Eur J Pediatr. 1993 Jan;152(1):44-50 - PubMed
  10. Pediatr Nephrol. 1994 Apr;8(2):164-8 - PubMed
  11. Kidney Int. 1994 May;45(5):1388-96 - PubMed
  12. Pediatr Neurol. 1995 Jul;13(1):69-72 - PubMed
  13. Mitochondrial DNA A DNA Mapp Seq Anal. 2016 Jul;27(4):3008-12 - PubMed
  14. J Med Case Rep. 2009 Nov 03;3:101 - PubMed
  15. Pediatr Nephrol. 2004 Jul;19(7):790-3 - PubMed
  16. Eur J Biochem. 1998 Oct 1;257(1):192-201 - PubMed
  17. Klin Monbl Augenheilkd. 2007 Apr;224(4):340-3 - PubMed
  18. Pediatr Nephrol. 2007 Jan;22(1):136-40 - PubMed
  19. Pediatr Neonatol. 2012 Aug;53(4):264-8 - PubMed
  20. Pediatr Nephrol. 2012 May;27(5):869-72 - PubMed

Publication Types

Grant support